Literature DB >> 17633019

Ubiquitination and TRAF signaling.

Gabriel Pineda1, Chee-Kwee Ea, Zhijian J Chen.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17633019     DOI： 10.1007/978-0-387-70630-6_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  27 in total

Review 1.  Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.

Authors:  Carl F Ware
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 2.  TRAF6 activation in multiple myeloma: a potential therapeutic target.

Authors:  Hong Liu; Samantha Tamashiro; Stavroula Baritaki; Manuel Penichet; Youhua Yu; Haiming Chen; James Berenson; Benjamin Bonavida
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-03-21

3.  Mechanism of ubiquitin transfer promoted by TRAF6.

Authors:  Tian-Min Fu; Chen Shen; Qiubai Li; Pengfei Zhang; Hao Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

4.  Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice.

Authors:  Hadley J Hartwell; Keiko Y Petrosky; James G Fox; Nelson D Horseman; Arlin B Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

5.  RNA sensor LGP2 inhibits TRAF ubiquitin ligase to negatively regulate innate immune signaling.

Authors:  Jean-Patrick Parisien; Jessica J Lenoir; Roli Mandhana; Kenny R Rodriguez; Kenin Qian; Annie M Bruns; Curt M Horvath
Journal:  EMBO Rep       Date:  2018-04-16       Impact factor: 8.807

6.  HOIL-1L interacting protein (HOIP) as an NF-kappaB regulating component of the CD40 signaling complex.

Authors:  Bruce S Hostager; Daniel K Fox; Douglas Whitten; Curtis G Wilkerson; Betty A Eipper; Victor P Francone; Paul B Rothman; John D Colgan
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

7.  Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling.

Authors:  Shu Zhu; Wen Pan; Peiqing Shi; Hanchao Gao; Fang Zhao; Xinyang Song; Yan Liu; Lihua Zhao; Xiaoxia Li; Yufang Shi; Youcun Qian
Journal:  J Exp Med       Date:  2010-11-15       Impact factor: 14.307

8.  c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation.

Authors:  Eugene Varfolomeev; Tatiana Goncharov; Anna V Fedorova; Jasmin N Dynek; Kerry Zobel; Kurt Deshayes; Wayne J Fairbrother; Domagoj Vucic
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

9.  Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines.

Authors:  Ping-Hui Tseng; Atsushi Matsuzawa; Weizhou Zhang; Takashi Mino; Dario A A Vignali; Michael Karin
Journal:  Nat Immunol       Date:  2009-11-08       Impact factor: 25.606

10.  The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation.

Authors:  Peyman Nakhaei; Thibault Mesplede; Mayra Solis; Qiang Sun; Tiejun Zhao; Long Yang; Tsung-Hsien Chuang; Carl F Ware; Rongtuan Lin; John Hiscott
Journal:  PLoS Pathog       Date:  2009-11-06       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.